YOLFTbeta
Shenzhen Salubris Pharmaceuticals Co Ltd

Shenzhen Salubris Pharmaceuticals Co Ltd

002294 · SHE · Healthcare / Drug Manufacturers - Specialty & Generic

29.65CNY-0.13 (-0.44%)

Price History

Full chart

Market Stats

Previous Close29.78
Open29.80
Day Range29.61 – 29.89
52-Week Range29.25 – 69.87
Volume7.43M
Market Cap34.18B
P/E (TTM)51.10
Forward P/E48.78
EPS0.60
Dividend Yield1.84%
Beta-0.25
50-Day Avg32.59
200-Day Avg43.60

About

Shenzhen Salubris Pharmaceuticals Co., Ltd. engages in the research, development, production, and sale of pharmaceuticals and medical devices in China. The company is involved in the production and supply of pharmaceutical products in the fields of chronic diseases, including cardiovascular and cerebrovascular diseases, diabetes, oncology, osteoporosis, anti-infective diseases, and chronic kidney diseases. It also engages in the research and development, production, and sale of high-end interventional medical devices, such as cardiovascular and cerebrovascular, peripheral vascular, structural heart disease, electrophysiology, and cardiac rhythm management. The company was incorporated in 1998 and is headquartered in Shenzhen, China. Shenzhen Salubris Pharmaceuticals Co., Ltd. operates as a subsidiary of Salubris Pharmaceuticals Co., Ltd.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Jie Yan
  • Employees4.09K
  • HeadquartersNo. 289 Digital Peninsula, Shenzhen, China, 518017, China
  • Websitehttps://www.salubris.com

Leadership

  • Mr. Jie YanGM & Director · b. 1972
  • Ms. Yun Kong CPACFO, Accounting Supervisor & Financial Manager · b. 1973
  • Mr. Ping ChenDeputy General Manager · b. 1970
  • Mr. Jianfeng YangSecretary of the Board of Directors & Non Independent Director · b. 1975
  • Ms. Song Ping ZhaoDeputy General Manager · b. 1970
  • Dr. Xie Heng M.D., Ph.D.Chief Medical Officer

Financials

Income Statement

Currency: CNY2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31
Total Revenue203.14M349.43M527.17M849.60M1.30B1.47B1.83B2.33B2.88B3.48B3.83B4.15B4.65B4.47B2.74B3.06B3.48B3.37B4.01B
Growth (%)-+72.01%+50.86%+61.16%+52.75%+13.65%+24.00%+27.26%+23.85%+20.64%+10.23%+8.35%+11.99%-3.90%-38.74%+11.68%+13.85%-3.35%+19.22%
Cost of Revenue107.10M185.87M259.36M376.41M555.59M559.86M465.84M565.06M763.88M912.29M949.88M785.06M943.67M964.55M847.87M811.29M1.00B1.07B1.14B
Gross Profit96.05M163.56M267.81M473.19M742.17M915.02M1.36B1.76B2.12B2.57B2.88B3.37B3.71B3.51B1.89B2.25B2.48B2.30B2.87B
Gross Margin47.28%46.81%50.80%55.70%57.19%62.04%74.53%75.72%73.50%73.77%75.22%81.10%79.71%78.42%69.04%73.47%71.26%68.34%71.64%
Operating Expense58.71M87.41M141.71M227.48M349.64M466.60M652.51M794.66M911.58M1.09B1.25B1.65B1.99B2.66B1.81B1.66B1.75B1.64B2.23B
Operating Income37.33M76.15M126.10M245.70M392.54M448.42M710.53M967.76M1.21B1.48B1.63B1.71B1.72B846.08M79.22M586.20M727.44M655.98M646.31M
Operating Margin18.38%21.79%23.92%28.92%30.25%30.40%38.85%41.58%41.88%42.51%42.52%41.28%36.97%18.93%2.89%19.17%20.89%19.49%16.11%
EBITDA41.80M84.20M136.72M263.78M435.39M485.16M752.03M1.00B1.23B1.53B1.71B1.76B1.81B1.05B552.33M798.40M873.67M893.22M1.04B
EBITDA Margin20.58%24.10%25.94%31.05%33.55%32.89%41.12%43.07%42.78%43.92%44.69%42.27%38.99%23.57%20.17%26.11%25.09%26.54%26.03%
Net Income34.24M73.14M116.94M215.75M355.31M405.25M635.17M830.42M1.04B1.27B1.40B1.45B1.46B715.20M60.86M533.73M637.09M580.07M601.57M
Net Income Margin16.85%20.93%22.18%25.39%27.38%27.48%34.73%35.68%36.16%36.40%36.43%34.95%31.35%16.00%2.22%17.45%18.30%17.24%14.99%
R&D----66.60M77.00M126.92M144.21M122.88M175.76M224.27M327.05M407.48M763.50M371.20M357.37M533.75M409.19M566.44M
R&D as % of Total Revenue----5.13%5.22%6.94%6.20%4.26%5.05%5.85%7.87%8.76%17.08%13.55%11.68%15.33%12.16%14.12%
Interest Expense324.68K932.88K2.04M1.17M371.65K612.27K433.44K280.23K245.37K253.14K679.22K305.81K6.49M16.16M18.11M10.88M12.54M17.87M17.70M
Interest Expense % of Total Revenue0.16%0.27%0.39%0.14%0.03%0.04%0.02%0.01%0.01%0.01%0.02%0.01%0.14%0.36%0.66%0.36%0.36%0.53%0.44%

Balance Sheet

Currency: CNY2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31
Total Assets158.66M255.94M408.60M1.77B2.17B2.45B2.98B3.64B4.62B5.39B6.53B6.86B7.90B7.73B6.93B9.24B9.76B9.40B10.47B
Total Liabilities52.19M109.98M145.70M148.59M309.50M310.52M374.02M508.36M827.95M691.25M1.07B705.86M1.03B1.07B1.34B1.20B1.78B1.34B1.71B
Total Equity106.48M145.96M262.90M1.62B1.86B2.13B2.60B3.13B3.78B4.59B5.36B6.05B6.66B6.49B5.51B8.03B7.94B8.02B8.71B
Cash6.65M33.93M52.27M1.16B1.01B889.48M958.77M694.24M851.42M1.01B1.71B828.92M645.11M1.11B865.13M3.24B2.67B1.32B1.13B
Total Debt13.68M33.55M64.20M------60.00M60.00M30.00M242.04M282.93M397.55M72.11M196.77M52.54M124.18M
Net Debt7.03M-379.08K11.93M-1.16B-1.01B-889.48M-958.77M-694.24M-851.42M-945.43M-1.65B-798.92M-403.07M-829.01M-467.58M-3.16B-2.47B-1.27B-1.00B

Cash Flow

Currency: CNY2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31
Operating Cash Flow12.00M52.75M77.89M134.28M186.65M272.32M521.21M668.52M982.25M1.06B1.43B1.46B1.34B1.51B1.37B1.18B970.80M839.44M1.19B
Investing Cash Flow-11.61M-11.81M-61.41M-132.68M-223.10M-251.55M-288.23M-627.19M-432.82M-445.88M-530.00M-1.20B-933.02M-212.31M-849.44M-369.65M-1.27B-1.37B-1.53B
Financing Cash Flow-953.16K-21.77M9.97M1.10B-117.10M-131.71M-163.44M-305.09M-392.29M-458.51M-200.05M-1.13B-597.23M-829.59M-766.86M1.55B-401.50M-705.54M121.84M
Capital Expenditure9.71M13.71M61.48M135.68M223.48M252.60M286.75M427.20M200.65M235.57M245.06M331.67M332.87M457.19M642.47M482.50M598.96M671.00M624.81M
Free Cash Flow2.30M39.05M16.41M-1.39M-36.83M19.72M234.46M241.32M781.59M820.46M1.19B1.13B1.01B1.05B731.86M702.48M371.84M168.44M561.45M
Dividends Paid564.76K30.72M2.33M2.77M113.50M136.20M163.44M305.09M392.26M458.84M206.40M1.16B843.45M852.75M515.93M1.60M437.56M545.68M546.04M
FCF to OCF19.15%74.02%21.07%-1.04%-19.73%7.24%44.98%36.10%79.57%77.69%82.92%77.25%75.17%69.66%53.25%59.28%38.30%20.07%47.33%
Dividend Paid to FCF24.56%78.67%14.18%-198.92%-308.18%690.70%69.71%126.43%50.19%55.93%17.35%103.11%83.69%81.26%70.50%0.23%117.67%323.95%97.26%

Earnings

Report DateMar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Jun 1, 2011Aug 31, 2011Nov 30, 2011Feb 29, 2012Apr 20, 2012Aug 13, 2012Oct 22, 2012Feb 27, 2013Apr 22, 2013Aug 28, 2013Oct 14, 2013Feb 26, 2014Apr 21, 2014Aug 18, 2014Oct 20, 2014Mar 24, 2015Apr 15, 2015Aug 24, 2015Oct 25, 2015Feb 26, 2016Apr 18, 2016Aug 22, 2016Oct 24, 2016Jan 23, 2017Apr 24, 2017Aug 24, 2017Oct 23, 2017Feb 26, 2018Apr 16, 2018Aug 20, 2018Oct 28, 2018Feb 27, 2019Apr 22, 2019Aug 27, 2019Oct 28, 2019Feb 28, 2020Apr 10, 2020Aug 26, 2020Oct 22, 2020Mar 29, 2021Apr 20, 2021Aug 23, 2021Oct 25, 2021Mar 28, 2022Apr 18, 2022Aug 9, 2022Oct 24, 2022Mar 28, 2023Apr 18, 2023Aug 24, 2023Oct 30, 2023Mar 25, 2024Apr 22, 2024Aug 26, 2024Oct 21, 2024Mar 28, 2025Apr 22, 2025Aug 20, 2025Oct 28, 2025Apr 21, 2026Aug 25, 2026
EPS Estimate--------0.120.120.14-0.17-0.19-0.210.240.210.250.290.300.340.380.290.390.380.380.340.370.360.380.320.430.430.550.320.170.420.330.270.140.130.610.130.200.140.120.130.420.150.110.200.090.140.110.180.160.130.14-----
EPS Actual0.080.090.070.100.100.090.090.110.120.110.170.190.190.180.190.230.250.220.240.280.300.290.290.320.340.320.330.340.360.340.350.340.400.350.340.280.290.290.09-0.010.140.050.07-0.200.150.070.160.120.220.090.180.090.190.110.130.090.180.130.150.080.180.150.190.200.15
Surprise--------0.00%-8.33%21.43%-11.76%-0.00%-19.05%-8.33%14.29%12.00%3.45%-3.33%-14.71%-15.79%17.24%-17.95%-13.16%-10.53%5.88%-8.11%-2.78%-10.53%25.00%-18.60%-20.93%-49.09%-9.38%70.59%-78.57%-103.03%-48.15%-64.29%-46.15%-132.79%15.38%-65.00%14.29%0.00%69.23%-78.57%20.00%-18.18%-5.00%22.22%-7.14%-18.18%0.00%-18.75%15.38%-42.86%-----
Timing--------After-hoursAfter-hoursAfter-hours-After-hours-After-hours-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-market----

Key Statistics & Ratios

Market Cap34.18B
Enterprise Value33.93B
Trailing P/E51.10
Forward P/E48.78
PEG Ratio1.17
Price / Sales7.27
Price / Book4.03
EPS0.60
Book Value7.71
Revenue (TTM)4.70B
Gross Profit (TTM)3.49B
EBITDA1.05B
Profit Margin14.33%
Operating Margin12.66%
Return on Equity7.68%
Return on Assets3.79%
Shares Outstanding1.11B
Shares Float438.57M
Beta-0.25
Dividend Yield1.84%
Dividend Rate0.55
Payout Ratio101.64%

Dividends

20261×
0.55May 26, 2026
20251×
0.50May 14, 2025
20241×
0.50Jun 19, 2024
20231×
0.50May 9, 2023
20221×
0.40Apr 27, 2022
20201×
0.50May 20, 2020
20191×
0.80Apr 16, 2019
20181×
0.80May 4, 2018
20171×
0.70May 12, 2017
20161×
0.60May 3, 2016
20151×
0.44Apr 24, 2015
20141×
0.38May 7, 2014
20131×
0.29May 9, 2013
20121×
0.16May 4, 2012
20111×
0.13May 3, 2011
20101×
0.05Apr 20, 2010

Stock Splits

  • Apr 24, 201516:10
  • May 9, 201315:10
  • May 4, 201212:10
  • May 3, 201116:10
  • Apr 20, 20102:1